domestic approval
Scope
Date
~
-
Pension funds
NPS logs 0.87% return from first-quarter investment
The National Pension Service (NPS), South Korea’s state-run pension fund and the country’s largest institutional investor, announced on ...
May 30, 2025 (Gmt+09:00)
-
Food & Beverage
Bird flu in Brazil hikes wholesale chicken prices in Korea
South Korea has suspended chicken imports from Brazil following the outbreak of highly pathogenic avian influenza (HPAI) in the South American count...
May 19, 2025 (Gmt+09:00)
-
Earnings
Dawn delivery pioneer Kurly posts 1st-ever quarterly profit
Kurly Inc., a pioneer in South Korea’s dawn delivery market, has posted its first-ever quarterly profit, bucking a slowdown in private consump...
May 13, 2025 (Gmt+09:00)
-
Debt financing
Korea Securities Finance eyes its 1st foreign bond sale in 2026
Korea Securities Finance Corp. (KSFC) is preparing to issue its first foreign currency-denominated bonds in 2026 to provide low-cost funding to dome...
May 09, 2025 (Gmt+09:00)
-
Woori Financial wins approval for Tongyang, ABL Life acquisition
Woori Financial Group Inc., South Korea’s fourth-largest financial services provider, has received conditional approval from the country&rsquo...
May 02, 2025 (Gmt+09:00)
-
Batteries
POSCO Future M to make spherical graphite as it cuts dependence on China
POSCO Future M Co., South Korea’s leading battery materials maker, is set to manufacture spherical graphite – a critical material for ba...
Apr 23, 2025 (Gmt+09:00)
-
Shipping & Shipbuilding
With domestic dockyards fully booked, Korean shipbuilders turn overseas
As order books swell amid green shipping mandates, LNG demand and military naval modernization, South Korean shipbuilders are extending their global...
Apr 14, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
-
Pension funds
S.Korea’s NPS to double pension fund size by 2050, hike risky assets
South Korea’s National Pension Service (NPS) is projected to nearly double its fund size to 3,500 trillion won ($2.38 trillion) by 2050, follo...
Mar 24, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Steel
Korea to probe Chinese, Japanese steel imports over anti-dumping claims
South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...
Feb 19, 2025 (Gmt+09:00)
-
Korean startups
Funding to Korean tech startups at 7-year low; seed funding soars
New funding to South Korean tech startups dropped to its lowest level in seven years in 2024. But seed funding soared 142% led by semiconductor, hea...
Feb 03, 2025 (Gmt+09:00)
-
Private equity
Korean lenders to Accell warn they may boycott KKR
KKR & Co. is facing a huge backlash from South Korean financial services firms after the debt restructuring of Dutch bicycle manufacturer Accell...
Jan 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Foreign exchange
Korea to relax FX rules by December to boost dollar selling
South Korea will raise the limits on forward dollar purchases and expand the foreign exchange swap line between the National Pension Service (NPS) a...
Dec 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Dec 16, 2024 (Gmt+09:00)
-
Automobiles
Korea’s commercial vehicle sales tumble on economic slowdown
South Korea’s commercial vehicle sales are plunging on sluggish domestic demand amid a slowdown in Asia’s fourth-largest economy.Local s...
Dec 12, 2024 (Gmt+09:00)
-
Capital raising
Korean firms halt bond, share issues despite tighter liquidity
South Korean companies are postponing bond issues and initial public offerings on chilled investor sentiment in the aftermath of President Yoon Suk ...
Dec 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Business & Politics
S.Korea's Yoon survives impeachment; economic fundamentals firm
South Korean President Yoon Suk Yeol survived an impeachment vote against him after an overwhelming majority of governing party lawmakers boycotted ...
Dec 07, 2024 (Gmt+09:00)
-
Corporate bonds
Korean companies’ cash reserves swell to record high
Cash holdings at South Korean companies have soared to a record-high level, data showed on Monday. Companies are stepping up efforts to raise cash t...
Dec 02, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Rebellions · Sapeon Korea merger, the first domestic AI chip unicorn
Rebellions Inc., a South Korean artificial intelligence chip design startup, officially merged with Sapeon Korea to form the first domestic AI chi...
Dec 02, 2024 (Gmt+09:00)
-
Venture capital
S.Korean startup accelerators to boost overseas biz
South Korean accelerators (ACs) are turning to Southeast Asia and the Middle East market to support startups and expand their reach.ACs, companies t...
Nov 29, 2024 (Gmt+09:00)
-
Airlines
Korean Air gets EU approval for Asiana merger
The European Commission (EC), the European Union (EU) antitrust body, approved the merger between Korean Air Lines Co. and Asiana Airlines Inc. on N...
Nov 29, 2024 (Gmt+09:00)
-
Corporate bonds
Triple-A rated SK Telecom, KT tap 10-year bond market
South Korean companies with top-notch credit ratings such as SK Telecom Co. and KT Corp. are returning to the long-term bond market amid growing int...
Nov 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets EC's approval for Opuviz
South Korea's Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, and the US-based Biogen said on Tuesday the European C...
Nov 19, 2024 (Gmt+09:00)
-
Batteries
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Nov 19, 2024 (Gmt+09:00)
-
Cryptocurrencies
Korea’s crypto exchanges ride bitcoin rally on Trump optimism
South Korea’s crypto exchanges are enjoying a global boom in virtual currencies, including bitcoin, as US President-elect Donald Trump is expe...
Nov 14, 2024 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet